EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Sunway Healthcare Holdings Berhad (5555) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Sunway Healthcare Holdings Berhad MYR 0.38, price MYR 2.13, upside -82.2%, quality 58 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · MY

SH Thin data Sep 24, 2026

Sunway Healthcare Holdings Berhad

5555 · KLSE

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value 0.3800 MYR · Strongly overvalued (−82%)
!Quality 58/100
!Mixed Growth (revenue YoY +27.2 %/yr)
✓Solidly profitable · 10.7% net margin (TTM)
!Moderate debt · negative free cash flow
!Mixed vs. peers (6/13)
!Moderate moat 46/100
!Evidence only low, so the estimate is less certain
!Weak on dividend: 1 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

2.37 MYR 1.73 MYR Fair Value 0.3800 MYR Mar 2026 Sep 2026

White line = price, green steps = our fair value per fiscal year. As of Sep 24, 2026.

How to read this chart

6‑month range 1.73 MYR – 2.37 MYR · fair‑value band 0.2900 MYR – 0.4800 MYR · the 2.13 MYR price screens above the 0.3800 MYR fair value. As of Sep 24, 2026.

Follow Sunway Healthcare Holdings Berhad in your weekly email

Every Wednesday you see whether Sunway Healthcare Holdings Berhad is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Sunway Healthcare Holdings Berhad, an investment holding company, owns and operates medical centers and facilities in Malaysia.

Show more

Sunway Healthcare Holdings Berhad, an investment holding company, owns and operates medical centers and facilities in Malaysia. The company provides medical consultation services and facilities, provision of financial services, provision of nursing manpower and nursing care services, operation and provision of traditional and complementary medicine centres, provision of facilities and services for senior living care and assistance, offers ambulatory care services, invests in property, and provision of training services. The company was incorporated in 2021 and is headquartered in Subang Jaya, Malaysia. Sunway Healthcare Holdings Berhad operates as a subsidiary of Sunway City Sdn. Bhd.

Stock analysis

Sunway Healthcare Holdings Berhad (5555) currently trades at 2.13 MYR, while our model-based Fair Value estimate is 0.3800 MYR, implying the stock looks roughly 460.5% overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 0.8200 MYR per share, and 0 of the 16 models we run sit above the 2.13 MYR price.

Bear case: the Asset-Based group reads lowest at 0.1400 MYR, and 16 of the 16 models stay below the price. Evidence for this calculation is low.

Scenario range: 0.2900 MYR (bear) to 0.4800 MYR (bull), the price of 2.13 MYR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 58/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Sunway Healthcare Holdings Berhad reported revenue of 1.9B MYR in FY2024 versus 1.1B MYR in FY2022, a compound +31.9%/yr. Reported net income was 258M MYR in FY2024, compounding +10.8%/yr from FY2022.

Key figures

Market cap 24.5B MYR (≈ $6.0B) · P/E ratio 106.5 · P/S ratio 14.8 · EPS (TTM) 0.0200 MYR · Dividend yield 0.1% · Net margin 13.9% · Return on equity 9.3% · Return on assets (EBIT) 5.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at −82%, 5555 screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (0.0200 MYR to 1.06 MYR). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear 0.2900 MYR Fair Value 0.3800 MYR Bull 0.4800 MYR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2024 figures (about 12 months old). Earnings retained since then (0.0200 MYR per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV 0.1100 MYR 0.1400 MYR 0.1600 MYR 71
EV/EBITDA 0.3200 MYR 0.4400 MYR 0.5700 MYR 67
Residual Income 0.1900 MYR 0.2100 MYR 0.3700 MYR 67
All 16 models by family
Earnings-Based
Graham-Dodd 0.1500 MYR 1.06 MYR 1.49 MYR 57
Lynch FV 0.4600 MYR 0.6600 MYR 0.8500 MYR 55
PEG = 1.0 0.4600 MYR 0.6600 MYR 0.8500 MYR 52
EPV 0.1100 MYR 0.1400 MYR 0.1600 MYR 71
Dividend Discount
Gordon GGM 0.0100 MYR 0.0200 MYR 0.0300 MYR 60
DDM Multi-Stage 0.0100 MYR 0.0200 MYR 0.0200 MYR 61
Multiples
P/E Multiple 0.3700 MYR 0.4900 MYR 0.6200 MYR 63
P/S Multiple 0.2900 MYR 0.3800 MYR 0.4800 MYR 58
P/B Multiple 0.2900 MYR 0.3800 MYR 0.4800 MYR 55
EV/EBIT 0.2400 MYR 0.3500 MYR 0.4500 MYR 65
EV/EBITDA 0.3200 MYR 0.4400 MYR 0.5700 MYR 67
EV/Revenue 0.1600 MYR 0.2500 MYR 0.3400 MYR 53
Asset-Based
NCAV (Graham) 0.1100 MYR 0.1400 MYR 0.2100 MYR 54
Economic Profit
Residual Income 0.1900 MYR 0.2100 MYR 0.3700 MYR 67
ROIC Compounder 0.1100 MYR 0.1400 MYR 0.1600 MYR 66
Growth Earnings
Growth-Adj P/E 0.5800 MYR 0.8200 MYR 1.07 MYR 61

Open the full fair value analysis →

Notify me when 5555 reaches fair value

Put 5555 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 58/100

Of which business quality 58 · Market factors (momentum, volatility) 51

Profitability 43
Margins and returns on capital today
Quality Growth 76
Are margins and returns improving?
Cashflow 39
Earnings quality: real cash, not paper profit
Fin. Strength 75
Balance sheet, leverage, solvency risk
Investment 38
Disciplined investing over empire-building
Low Volatility 55
Calm price path (market factor)
Momentum 50
Price trend over the last 3–12 months (market factor)
52W Momentum 50
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 49/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed

5555 screens 461% overvalued. Compare with HCA Healthcare, Inc →

Compare Sunway Healthcare Holdings Berhad with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 257 stocks

Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 58 · Above median
Fair Value upside −82% · Bottom 25%
Profitability
Return on equity (TTM) 9% · Above median
Return on assets 4% · Above median
Net margin (TTM) 11% · Above median
Operating margin (TTM) 10% · Above median
Growth and dividend
Revenue growth 24% · Top 25%
Dividend yield (TTM) 0.1% · Bottom 25%
Balance sheet
Debt / equity 0.52× · Highest 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (TTM) 106.5× · Priciest 25%
P/B 2.44× · Pricier than median
P/S (TTM) 2.60× · Priciest 25%
EV/EBITDA 13.7× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 33
FUTURE (revenue growth)100 · sector 29
PAST (return on equity)37 · sector 31
HEALTH (low debt)74 · sector 89
DIVIDEND (yield)1 · sector 42

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $438.12 $592.64 +35%
Fresenius SE FRE €45.57 €34.54 −24%
Dr. Sulaiman Al Habib Medical Services Group 4013 227.50 SAR 109.45 SAR −52%
IHH Healthcare Berhad, an investment holding company, 5225 8.00 MYR 4.87 MYR −39%
Tenet Healthcare Corporation THC $262.06 $399.58 +52%
DaVita Inc DVA $183.72 $255.97 +39%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹9,069 ₹2,908 −68%
Fresenius Medical Care AG FME €39.30 €71.28 +81%
Aier Eye Hospital Group 300015 ¥8.07 ¥10.86 +35%
Encompass Health Corporation EHC $122.76 $96.51 −21%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Sunway Healthcare Holdings Berhad Fair Value". https://www.fairvalue-calculator.com/stock/5555

Frequently asked questions

Is Sunway Healthcare Holdings Berhad (5555) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 0.3800 MYR versus a price of 2.13 MYR, about −82% upside (overvalued).
What is the fair value of 5555?
Our model-based fair value for Sunway Healthcare Holdings Berhad is 0.3800 MYR (as of Sep 24, 2026), built from audited fundamentals. The current price: 2.13 MYR.
What is the quality score of 5555?
Sunway Healthcare Holdings Berhad has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sunway Healthcare Holdings Berhad (5555)?
Our model-based price target is the fair value of 0.3800 MYR (as of Sep 24, 2026) from 16 valuation models. Cautious scenario 0.2900 MYR, optimistic scenario 0.4800 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Sunway Healthcare Holdings Berhad stock forecast for 2026?
Our models put fair value at 0.3800 MYR, about −82% upside versus a price of 2.13 MYR (overvalued). Cautious scenario 0.2900 MYR, optimistic scenario 0.4800 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Sunway Healthcare Holdings Berhad (5555)?
Sunway Healthcare Holdings Berhad reported trailing-twelve-month revenue of about 2.3B MYR (latest available figure, as of Sep 24, 2026).
Does Sunway Healthcare Holdings Berhad pay a dividend?
Sunway Healthcare Holdings Berhad currently shows a dividend yield of about 0.05% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Sunway Healthcare Holdings Berhad (5555)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sunway Healthcare Holdings Berhad it is 0.3800 MYR per share (as of Sep 24, 2026), against a price of 2.13 MYR. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Sunway Healthcare Holdings Berhad stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 5555 trades above its calculated fair value: price 2.13 MYR, fair value 0.3800 MYR, a gap of about −82% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 5555?
No. The price is what the market pays today (2.13 MYR); the fair value is what the company's own numbers justify (0.3800 MYR). For Sunway Healthcare Holdings Berhad the two are 1.75 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Sunway Healthcare Holdings Berhad worth?
The market values Sunway Healthcare Holdings Berhad at about 24.5B MYR (market capitalisation, as of Sep 24, 2026). Per share that is 2.13 MYR; our models calculate a fair value of 0.3800 MYR per share.
What do the bullish and bearish scenarios say about 5555?
Our models span a range for Sunway Healthcare Holdings Berhad: cautious scenario 0.2900 MYR, base 0.3800 MYR, optimistic 0.4800 MYR per share (as of Sep 24, 2026, price 2.13 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 5555?
Sunway Healthcare Holdings Berhad trades at a price-to-earnings ratio of 106.5 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.3800 MYR is built from several models across several years. Other multiples: P/B 2.4, P/S 2.6, EV/EBITDA 13.7.
How solid is the balance sheet of Sunway Healthcare Holdings Berhad (5555)?
Balance-sheet figures for Sunway Healthcare Holdings Berhad (as of Sep 24, 2026): return on equity 9.3%, debt of 0.52 per unit of equity. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
Which stocks are comparable to Sunway Healthcare Holdings Berhad?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sunway Healthcare Holdings Berhad stock attractive at the current price?
The data as of Sep 24, 2026: price 2.13 MYR, calculated fair value 0.3800 MYR (−82%), Quality Score 58/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 5555 calculated?
We run Sunway Healthcare Holdings Berhad through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.3800 MYR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Sunway Healthcare Holdings Berhad itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sunway Healthcare Holdings Berhad (5555)?
The closing price on Sep 23, 2026 was 2.13 MYR. Our model-based fair value is 0.3800 MYR, about −82% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sunway Healthcare Holdings Berhad right now?
The price sits above even our optimistic bull case (0.4800 MYR). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (58/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Sunway Healthcare Holdings Berhad

How large is the market capitalisation of Sunway Healthcare Holdings Berhad (5555)?
The market capitalisation of Sunway Healthcare Holdings Berhad is 24.5B MYR (≈ $6.0B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sunway Healthcare Holdings Berhad (5555)?
The price-to-sales ratio of Sunway Healthcare Holdings Berhad is 14.8 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Sunway Healthcare Holdings Berhad (5555)?
Earnings per share at Sunway Healthcare Holdings Berhad are 0.0200 MYR (price ÷ EPS = P/E 106.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Sunway Healthcare Holdings Berhad (5555)?
The dividend yield of Sunway Healthcare Holdings Berhad is 0.1% (payout 5.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Sunway Healthcare Holdings Berhad (5555)?
The net margin of Sunway Healthcare Holdings Berhad is 13.9% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Sunway Healthcare Holdings Berhad (5555)?
The return on equity (ROE) of Sunway Healthcare Holdings Berhad is 9.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Sunway Healthcare Holdings Berhad (5555)?
On an EBIT basis the return on assets of Sunway Healthcare Holdings Berhad is 5.8% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sunway Healthcare Holdings Berhad (5555)?
The operating margin of Sunway Healthcare Holdings Berhad is 9.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sunway Healthcare Holdings Berhad (5555)?
Revenue at Sunway Healthcare Holdings Berhad is growing +23.8% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Sunway Healthcare Holdings Berhad (5555)?
Earnings per share at Sunway Healthcare Holdings Berhad are growing −14.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Sunway Healthcare Holdings Berhad (5555) generate?
The free cash flow of Sunway Healthcare Holdings Berhad is −118M MYR (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Sunway Healthcare Holdings Berhad (5555) carry?
The net debt of Sunway Healthcare Holdings Berhad is 1.0B MYR (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Sunway Healthcare Holdings Berhad in the live analysis

One click puts Sunway Healthcare Holdings Berhad on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.